Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Leverage Brain Inc.（株式会社レバレッジブレーン） is a clinical trial and research support company based in Shibuya, Tokyo, Japan. It focuses on human clinical trials for foods, monitoring surveys, marketing research, and related system development and system operation support. Strictly speaking, it is not a general-purpose enterprise SaaS provider, but rather a vertical industry solutions provider centered on CRO/research operations services, with its subject management app “e-DCA.”
The company emphasizes applying its experience in pharmaceutical GCP clinical development to human clinical trials for foods, covering the full process from trial design, protocol and document preparation, selection of implementing medical institutions, ethics review applications, subject recruitment, support for obtaining consent, subject management, data management, statistical analysis, and manuscript submission. Its e-DCA app supports smartphone-based daily diaries, questionnaires, VAS scales, scheduled reminders, chat communication, real-time monitoring, and CSV export, helping improve compliance while reducing the cost of paper-based management.
The official website does not disclose plans, pricing, payment methods, free versions, or trial information. All services require inquiry via a contact form. e-DCA data is managed in the cloud, and clients can view aggregated data. The app is not publicly released on the iTunes Store or Google Play; instead, QR codes are distributed to subjects on a project basis.
Its strengths lie in the team’s experience with both food and pharmaceutical clinical trials, enabling end-to-end support from study design through publication. e-DCA is designed around subject management scenarios, supporting reminders, chat, and timestamped records, and can be customized according to the trial protocol. Its limitations are that the official website lacks standardized SaaS procurement information, such as APIs, third-party integrations, permission models, SLAs, compliance certifications, and detailed security architecture. The product leans more toward project-based services, and its ability to support scalable self-service purchasing is unclear.
It is suitable for companies or research institutions in the Japanese market that need to conduct human clinical trials related to foods and health supplements, post-marketing surveillance, real-world data collection, and subject compliance management. If a company is looking for a general-purpose EDC, CTMS, or global clinical SaaS platform, it will need to further confirm the system’s capabilities and integration options.
Based on the crawled text, its access stability in mainland China cannot be determined and is currently marked as unknown.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on levbrain.com official site.
levbrain.com is an Japan Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach levbrain.com directly.